In our study, we evaluated the nuclear and cytoplasmic immunohistochemical expression of CD25 and the phosphorylated form of NFkB in thyroid carcinoma, thyroid adenoma, and HT. The gene discussed is NFKB1; the disease is Thyroid adenoma.